Jul 10, 2024 · A medicine initially developed as a possible cancer treatment — saracatinib — is now being tested in Alzheimer's disease. In mice, saracatinib turned off a protein that allowed synapses to start working again.

You may need treatment for depression, sleep problems, hallucinations, parkinsonism or agitation. The U.S. Food and Drug Administration (FDA) has approved lecanemab (Leqembi) and donanemab (Kisunla) for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease.

Nov 8, 2024 · Work closely with your healthcare team to create a safe treatment plan. Tell your healthcare team about your prescriptions and any medicines or supplements taken without a prescription. Omega-3 fatty acids. Omega-3 fatty acids in fish or from supplements may lower the risk of dementia.

Some causes of dementia-like symptoms can be reversed with treatment. They include: Infections and immune disorders. Dementia-like symptoms can result from a fever or other side effects of the body's attempt to fight off an infection.

Jul 10, 2024 · Alzheimer's has no cure, but certain medicines can help manage symptoms of the disease and some can slow down disease progression. By Mayo Clinic Staff

Learn whether drugs to treat Alzheimer's disease like lecanemab (Leqembi), available at the Alzheimer's Disease Treatment Clinic, might benefit you.

Sep 25, 2024 · Each year, Mayo Clinic doctors care for more than 3,700 people with dementia including Alzheimer's disease, Lewy body dementia and frontotemporal dementia.

Nov 8, 2024 · There is no cure for Alzheimer's disease. In advanced stages, loss of brain function can cause dehydration, poor nutrition or infection. These complications can result in death.

Nov 28, 2023 · There's currently no cure or treatment for frontotemporal dementia, although research into treatments is ongoing. Medicines used to treat or slow Alzheimer's disease don't seem to be helpful for people with frontotemporal dementia.

Nov 28, 2023 · Mayo Clinic experts evaluate and treat more than 250 people with frontotemporal dementia each year. Cutting-edge research. Mayo Clinic researchers study risk and genetic factors, diagnostic techniques, and treatment options for …